Apollomics, a Company Developing Novel Oncology Therapies to

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq

Apollomics, a Company Developing Novel Oncology Therapies to Address Difficult-to-Treat Cancers, Announces Closing of Business Combination and Listing on Nasdaq
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , China , Glenns Vraniak , Jonathan Wang , Jane Wang , Kennethc Carter , Sanjeev Redkar , Guo Liang Yu , Sean Leous , Peter Vozzo , Wendy Hayes , Moses Chen , Hong Jung Moses Chen , China National Medical Products Administration , Drug Administration , Maxpro Capital Acquisition Corp , Nasdaq , Apollomics Inc , Exchange Commission , White Case , Apollomic Co , Securities Exchange , Nelson Mullins Riley Scarborough , Maxpro Capital Acquisition , Apollomic Class , Nasdaq Capital Market , Business Combination , Breakthrough Therapy Designation , Chief Executive Officer , Apollomic Co Founder , Chief Scientific Officer , Chief Medical , Apollomic Board , Benchmark Investments , Nelson Mullins Riley , Securities Act , Securities Exchange Act ,